Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Julphar
Farmers Insurance
Chubb
McKinsey
Novartis
Fuji
Cipla
McKesson
Moodys

Generated: October 23, 2017

DrugPatentWatch Database Preview

COMTAN Drug Profile

« Back to Dashboard

What is the patent landscape for Comtan, and what generic Comtan alternatives are available?

Comtan is a drug marketed by Orion Pharma and is included in one NDA. There is one patent protecting this drug and one Paragraph IV challenge.

This drug has forty-eight patent family members in thirty-seven countries.

The generic ingredient in COMTAN is entacapone. There are nineteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the entacapone profile page.

Summary for Tradename: COMTAN

US Patents:1
Applicants:1
NDAs:1
Suppliers / Packagers: see list12
Bulk Api Vendors: see list45
Clinical Trials: see list4
Patent Applications: see list2,515
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:COMTAN at DailyMed

Pharmacology for Tradename: COMTAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Orion Pharma
COMTAN
entacapone
TABLET;ORAL020796-001Oct 19, 1999ABRXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: COMTAN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Orion Pharma
COMTAN
entacapone
TABLET;ORAL020796-001Oct 19, 1999► Subscribe► Subscribe
Orion Pharma
COMTAN
entacapone
TABLET;ORAL020796-001Oct 19, 1999► Subscribe► Subscribe
Orion Pharma
COMTAN
entacapone
TABLET;ORAL020796-001Oct 19, 1999► Subscribe► Subscribe
Orion Pharma
COMTAN
entacapone
TABLET;ORAL020796-001Oct 19, 1999► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for COMTAN

Drugname Dosage Strength RLD Submissiondate
entacaponeTablets200 mgComtan4/11/2007

International Patent Family for Tradename: COMTAN

Country Document Number Estimated Expiration
Malaysia124394► Subscribe
European Patent Office1112065► Subscribe
Georgia, Republic ofP20033062► Subscribe
Brazil9913681► Subscribe
Australia5748299► Subscribe
Norway20011278► Subscribe
South Africa200102084► Subscribe
Israel141681► Subscribe
Peru10602000► Subscribe
Estonia200100147► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Cantor Fitzgerald
Medtronic
McKinsey
Colorcon
Moodys
Accenture
Express Scripts
UBS
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot